October 01, 2024

PAH Study Critique: Selexipag's Real-World Impact

Real-world data analysis reveals early selexipag addition may reduce hospitalization risk in PAH patients, but study design limitations warrant cautious interpretation.

Conexiant

September 26, 2024

PTSD Widespread Among Nursing Aides After ‘Nightmare’ COVID Conditions

Nursing assistants at the Massachusetts Veterans Home in Holyoke faced traumatic experiences during the COVID-19 pandemic, leading to mental and physical tolls. Despite the lack of support, they struggle to access retirement benefits amidst ongoing trauma.

KFF Health News

April 25, 2024

AHA: 2023’s Most Significant Scientific Advancements in Cardiovascular Care

The AHA provided an overview of the most notable advancements in cardiovascular disease research in 2023.

Conexiant

April 25, 2024

Death of Pharmacist Serves as Warning to Seek Immediate Medical Attention for Adverse Cardiac Events and the Effects of Work-Related Stress

Experts warned of the risks of work-related stress following the death of a 41-year-old pharmacist in 2021.

Conexiant

May 06, 2024

Stranded in the ER, Seniors Await Hospital Care and Suffer Avoidable Harm

Amid hospital bed shortages and staff limitations, older adults in emergency rooms face prolonged waits and inadequate care, presenting serious health risks.

KFF Health News

May 17, 2024

Watch: John Oliver Dishes on KFF Health News’ Opioid Settlements Series

Recent reporting and analysis show how opioid settlement funds are being allocated by state and local governments in the US, shedding light on the significant restitution efforts by manufacturers, distributors, and retailers.

KFF Health News

February 28, 2024

Expert Point of View: Carlos L. Arteaga, MD

Dr. Carlos L. Arteaga discusses the significant benefits of structured exercise recommendations for cancer patients, advocating for universalizing this approach, while sharing insights from the PREFERABLE-EFFECT trial.

The ASCO Post

June 11, 2024

Merck Targets Cardiometabolic Revolution with Cutting-Edge Drug Advances

Merck is pursuing next-generation cardiometabolic drug opportunities, focusing on small-molecule oral treatments with potential benefits beyond weight loss, including improvements in cardiovascular and diabetes outcomes.

Reuters

March 10, 2023

Improving Physician-Patient Communication

ASCO's 2017 guideline in the Journal of Clinical Oncology offers recommendations to enhance patient-clinician communication and promote patient-centered oncology care.

The ASCO Post